Navigation Links
New FT-IR Spectrometer Series from Varian, Inc.
Date:3/31/2008

Unrivalled Performance Meets Simplicity for Routine and Research

Applications

PALO ALTO, Calif., March 31 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) announced today its new 600-IR series of FT-IR (Fourier Transform Infrared) spectrometers, microscopes and imaging solutions. The series comprises a range of products for both routine analyses and advanced research applications.

FT-IR spectroscopy provides a simple, fast analytical tool to identify or characterize samples in a wide range of applications from QA/QC testing of raw materials in pharmaceutical laboratories to the detection of trace amounts of explosives or narcotics in forensic analysis.

FT-IR spectroscopy also has the ability to reveal the chemical fingerprint of a material, even in mixtures, allowing multiple materials to be identified simultaneously. Commonly used with a wide range of accessories such as ATR (Attenuated Total Reflectance), microscopes and imaging, FT-IR has pioneered new applications in areas such as biotechnology, food and agriculture and homeland security.

The Varian 600-IR series of spectrometers deliver the highest energy throughput, making them the ideal solution for research or method development applications. Designed for unrivalled performance, this new range of spectrometers and microscopes enables users to run samples faster, while maintaining the highest accuracy and reproducibility, saving both time and money.

Combining power with simplicity, the Varian 600-IR series intuitive, easy- to-use software and "plug and play" hardware simplify analyses and maximize output for both novice and expert users. The ability for users to upgrade their new instrumentation ensures that they can purchase a system that fits their budget today and will meet their needs in the future.

"The 600-IR Series offers unrivalled performance under real world conditions," said Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "The combination of superior performance and reduced complexity offers information rich detection to users in a broad range of applications."

For more technical information about Varian's FT-IR instrumentation, please visit http://www.varianinc.com/products/

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,900 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site: http://www.varianinc.com.

For More Information, Contact:

Public Relations

Varian, Inc.

650.424.3845

pr@varianinc.com


'/>"/>
SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Transave, Inc. Raises $35 Million Through Series D Convertible Preferred Stock Financing
2. Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
3. LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series C Financing Round
4. Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing
5. U.S. FDA Licenses DAPTACEL(R) Vaccine for the Fifth Consecutive Dose in the Pediatric DTaP Immunization Series
6. Mercury Therapeutics, Inc: Lead Series of Indirect AMPK Activators Licensed to Makoto Life Sciences
7. New nanotechnology television series does sweat the small stuff
8. BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
9. Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race
10. National Stem Cell Holding, Inc. to Present Keynote Address at The Stem Cell Partnering Series Inaugural Meeting in San Diego
11. The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Feb. 24, 2017  Aethlon Medical, Inc. (Nasdaq: ... by its Chairman and CEO, Jim Joyce . ... Security Conference last Saturday, Bill Gates warned ... more people than nuclear weapons. Mr. Gates expressed his ... intelligence agencies, that scientific terrorists have access to the ...
(Date:2/24/2017)... Staten Island, NY (PRWEB) , ... February 24, 2017 , ... ... exponential rate. Founded in late 2014, FireflySci had the goal of bringing their ... 2017, that goal continues to shape the path that FireflySci is going on as ...
(Date:2/23/2017)... and NEW YORK ... HIMSS, Lumeon , a leading digital health ... Telehealth), a provider of telemedicine and remote patient ... pathways for telemedicine reimbursements.  DN ... their patients, in real-time, extending consultations beyond a ...
(Date:2/23/2017)... JOSE, Calif. , Feb. 23, 2017 /PRNewswire/ ... exclusive license for two key immunotherapy technologies from ... first technology provides a method to monitor a ... such as PD-L1 and CTLA-4.  The second license ... if a patient is likely to have an ...
Breaking Biology Technology:
(Date:2/9/2017)... 2017 The biomass boiler market report by ... boiler market globally in terms of revenue (US$ Mn) ... market for biomass boilers has been segmented on the ... country/region. The market based on feedstock type, has been ... & energy crops, urban residues, and others. On the ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global ... reach $11.4 billion by 2021, growing at a compound annual ... - An overview of the global markets for synthetic biology. ... estimates for 2016, and projections of compound annual growth rates ...
(Date:2/7/2017)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the latest release of ... and award winning eClinical solution, is now available for ... a proven Software-as-a-Service (SaaS) clinical research technology platform that ... delivers an entire suite of eClinical tools to support ...
Breaking Biology News(10 mins):